XML 74 R42.htm IDEA: XBRL DOCUMENT v3.25.2
Share-Based Compensation (Tables)
12 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-Based Compensation Plans Total share-based compensation included as a component of selling, general and administrative expenses in our Consolidated Income Statements was as follows:
 Fiscal Year Ended June 30,
 202520242023
 (in thousands)
Share-based compensation related to:
Equity classified stock options$ $550 $1,426 
Equity classified restricted stock11,062 8,987 9,793 
Total share-based compensation$11,062 $9,537 $11,219 
Schedule of Stock Option Plans
A summary of activity under our stock option plans is presented below:

 Fiscal Year Ended June 30, 2025
 OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
Outstanding, beginning of year711,952 $33.38 
Granted during the period— — 
Exercised during the period(276,289)34.43 
Canceled, forfeited, or expired during the period— — 
Outstanding, end of year435,663 32.71 2.87$3,965,747 
Vested at June 30, 2025435,663 32.71 2.87$3,965,747 
Exercisable, end of year435,663 $32.71 2.87$3,965,747 
Schedule of Stock Options Outstanding The following table summarizes information about stock options outstanding and exercisable as of June 30, 2025:
 Options OutstandingOptions Exercisable
Range of Exercise PricesShares
  Outstanding
Weighted
Average
Remaining
  Contractual Life
Weighted Average
Exercise
Price
Number ExercisableWeighted Average
Exercise
Price
$22.27 - $26.38
56,724 5.3824.59 56,724 24.59 
$26.38 - $30.49
119,021 5.4027.14 119,021 27.14 
$30.49 - $34.60
53,079 2.4434.35 53,079 34.35 
$34.60 - $38.71
206,839 0.8237.72 206,839 37.72 
435,663 2.87$32.71 435,663 $32.71 
Schedule of Restricted Stock Outstanding
During the fiscal year ended June 30, 2025, the Company granted 316,433 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs:
 Fiscal Year Ended June 30, 2025
 Shares
granted
Date grantedGrant date
fair value
Vesting period
Employees
Certain employees based on performance196,356 August 30, 2024$50.94 
Annually over 4 years
Certain employees based on performance80,391 August 30, 2024$55.78 
Annually over 3 years
Certain employees based on hire14,723 September 1, 2024$50.94 
Annually over 4 years
Certain employees based on performance2,976 December 1, 2024$50.41 
Annually over 4 years
Non-Employee Directors
Certain Directors21,987 August 30, 2024$50.94 
12 months

A summary of the status of the Company’s outstanding restricted stock is presented below:

 Fiscal Year Ended June 30, 2025
 SharesWeighted-Average
Grant Date Fair
Value
Outstanding, beginning of year887,310 $31.51 
Granted during the period316,433 51.55 
Vested during the period(281,962)33.71 
Cancelled, forfeited, or expired during the period(20,526)34.65 
Outstanding, end of year901,255 $40.52